🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies if itacitinib plus standard of care treatment m...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-01-11
Trial ID
NCT04859946
This is a study of itacitinib (INCB039110) in patients with myelofibrosis. ...
Status
Completed
Location
Birmingham Hematology Oncology Associates, LLC
Start Date
2012-07-16
Trial ID
NCT01633372
Treatments Being Tested
This is a single center, single arm phase 2 study to establish the safety a...
Status
Terminated
Location
University of Pennsylvania
Start Date
2018-06-18
Trial ID
NCT03425006
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of ita...
Status
Completed
Location
University of California San Diego, 3855 Health Sciences Drive, Mc 0987
Start Date
2016-12-20
Trial ID
NCT02917993
Treatments Being Tested
The purpose of this study is to evaluate itacitinib or placebo in combinati...
Status
Completed
Location
University of California, San Diego (UCSD) - Moores Cancer Center
Start Date
2017-07-19
Trial ID
NCT03139604
Treatments Being Tested
This study is being done in patients who have been receiving corticosteroid...
Status
Terminated
Location
Colorado Blood Cancer Institute
Start Date
2020-06-05
Trial ID
NCT04200365
Treatments Being Tested
To determine if Itacitinib in combination with corticosteroids is safe and ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02614612
Treatments Being Tested
The study's primary objective is designed to assess the safety and tolerabi...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-01-20
Trial ID
NCT04070781
Treatments Being Tested
This is a Phase 2, multicenter, open-label study to provide continued suppl...
Status
Active Not Recruiting
Location
Uab Comprehensive Cancer Center
Start Date
2020-08-03
Trial ID
NCT04509700
Treatments Being Tested
This pilot phase I trial studies how well itacitinib works in treating pati...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-09-30
Trial ID
NCT03670069
Treatments Being Tested